CDC recommends RSV monoclonal antibody for infants, high-risk young children
A panel of advisers to the CDC unanimously voted Thursday to recommend wide use among infants and some high-risk children of an antibody designed to protect against RSV.
A panel of advisers to the Centers for Disease Control and Prevention unanimously voted Thursday to recommend wide use among infants and some high-risk children of an antibody designed to protect against RSV, the country’s leading cause of infant hospitalization.
The 10-0 recommendation from the Advisory Committee on Immunization Practices was adopted hours later by CDC Director Mandy Cohen.
What's Your Reaction?
